Stock fact sheet · data as of

Neuberger High Yield Strategies Fund Inc. (NHS): fair value, margin of safety and Wheel Score

Financial Services · Asset Management · United States · High Yield Income

Close5.35
GLS fair value9.629 of 9 models
Margin of safety+44%price below fair value
Wheel Score39No optionscapped: no options
Health5/9Piotroski F-score
Moat2.2/10GLS 10-year score
Market cap$168M303k shares a day
Implied vol.-no listed options
P/E20.5EPS 0.26
Dividend yield20.30%payout 160%
Beta0.76moves less than the market
Next earnings-no date recorded

Is NHS undervalued?

NHS has a margin of safety of 44%: the stock closed at 5.35 on 16 Oct 2026 against a GLS average fair value of 9.62. 6 of the 9 valuation models that produced a number sit above the price. Our screens treat a discount this large as a strong starting point for a cash-secured put, not as a verdict - the fair value is a model output, and a wide gap can mean the models are missing something the market knows.

There is a wide gap between EPV (2.89) and DDM (15.98). When the models are this far apart the "fair value" is really a range, and the margin of safety above should be read with that range in mind.

The nightly engine files NHS under High Yield Income: a dividend yield above 4%.

Nine valuation models for NHS

Each model turns the latest filed numbers into a value per share; the GLS fair value is the simple average of the ones that produce a positive number. The last two rows are shown for reference and never enter the average. The Quote page lets you switch any model off and add your own margin of safety.

ModelValuevs priceWhat it measures
DCF13.85+159%Present value of the projected free cash flows, discounted at the cost of capital
Graham Number4.56-15%The most a defensive investor pays for the earnings and book value per share
Graham Growth14.89+178%Graham's growth formula: EPS × (8.5 + 2 × growth), adjusted for bond yields
Lynch6.51+22%EPS × the earnings growth rate (PEG of 1), growth capped at 25%
GLS Growth15.94+198%EPS compounded ten years at the blended growth rate, discounted back at 15% a year
10 Cap4.03-25%Owner's earnings (operating cash flow less maintenance capex) capitalised at 10%
Payback Time7.97+49%Eight years of compounded free cash flow: the price at which the business pays for itself
DDM15.98+199%Dividend discount model: next year's dividend ÷ (10% − 3% growth); needs a dividend
EPV2.89-46%Earnings power value: current EPS capitalised at 9% with no growth
Zombie (liquidation)-3.38-163%Current assets less all liabilities, per share: the balance-sheet floor. Not in the average
Wall St target0.0000-100%Analysts' average 12-month price target. Not in the average

Quality and financial health

Neuberger High Yield Strategies Fund Inc. scores 5 of 9 on the Piotroski F-score: a middling result that falls one point short of the Sunday Scan's "6 or more" rule. Some of the nine tests on profitability, leverage and efficiency are failed, so the accounts are worth a look before selling a put on the name. A GLS Moat score of 2.2/10 is a weak reading: the ten-year history the score grades (revenue, EPS, book value, margins, cash flow, share count, ROIC) has not been steady, so the Moat part of the Wheel Score contributes little.

Returns on capital are moderate - ROIC 6.0%, ROE 8.7%, ROA 5.9% - with debt at 0.43 times equity and a free-cash-flow yield of 9.6%.

The dividend yield is high at 20.30% (payout ratio 160%) - a payout above 100% of earnings, which is not covered by profits. A yield this size is often the market's way of pricing a risk to the payout, so the health score and cash flow matter more than usual.

Institutional ownership scores 1/10, insider activity 10/10 and Congressional trading 5/10 on the GLS smart-money scales.

Piotroski F-score5 / 9ROIC6.0%
GLS Moat2.2 / 10ROE8.7%
Debt / equity0.43ROA5.9%
Free-cash-flow yield9.6%Payout ratio160%
Institutions1 / 10Insiders · Congress10 · 5 / 10

Wheel Score 39: No options

No options are listed on Neuberger High Yield Strategies Fund Inc. in our nightly snapshot. The Wheel Score is therefore capped at 39 (it reads 39) and the stock is left out of every options screen; the fair value and health figures above are still useful for a plain stock position.

Volume runs at 303k shares a day on a market cap of $168M, with a beta of 0.76 - a low beta, so day-to-day moves are smaller than the market's; the Stability part of the Wheel Score gives that 9 of 20.

PartPointsFrom
Value25 / 2544% margin of safety
Health11 / 20Piotroski 5/9
Moat3 / 15moat 2.2/10
Premium0 / 20no option data
Stability9 / 20303k shares/day, $168M cap, beta 0.76

The Wheel Score ranks ~7,400 US stocks for selling cash-secured puts and covered calls; it is updated nightly and is not a recommendation. The walkthrough lesson shows how the score fits into a trade, start to finish.

Upcoming events

No upcoming earnings date is recorded for NHS in the nightly calendar.

Earnings, dividend, IPO, split and economic calendars for the whole market, filterable to your watchlists.

Similar stocks in Asset Management

The 12 companies below are the closest to Neuberger High Yield Strategies Fund Inc. by market cap within the Asset Management industry, each with its own fact sheet; the Compare page puts up to eight of them side by side.

StockCloseFair valueMoSWheelMkt cap
BSL
Blackstone Senior Floating Rate 2027 Term Fund
12.9314.41+10%36No options$168M
AMBR
Amber International Holding Ltd
1.81--35Weak$170M
GF
The New Germany Fund, Inc.
10.224.18-145%20No options$165M
OPP
RiverNorth/DoubleLine Strategic Opportunity Fund, Inc.
6.8826.02+74%39No options$172M
FHAYX
Fidelity Freedom Blend 2010 Fund
11.1121.11+47%39No options$164M
FLC
Flaherty & Crumrine Total Return Fund Inc.
15.5433.35+53%39No options$162M
ECF
Ellsworth Growth and Income Fund Ltd.
11.8076.61+85%39No options$161M
NESIX
Needham Small Cap Growth Institutional
30.0849.27+39%39No options$161M
DHF
BNY Mellon High Yield Strategies Fund
2.194.94+56%39No options$159M
WHF
WhiteHorse Finance, Inc.
7.4019.24+62%71Good$159M
WHFCL
WhiteHorse Finance, Inc. 7.875% Notes due 2028
25.1329.80+16%39No options$159M
ARHVX
American Century One Choice 2065 Inv
14.884.57-226%16No options$159M

⚖ Compare NHS with 7 of them   All Financial Services stocks →

Screen the whole market the same way

A free GLS Equity account gets you nightly fair value and the Wheel Score on ~7,400 US stocks, a watchlist, the scanner preview and the Sunday Scan - the same eight-rule screen, emailed every week. Pro adds the full put and call scanners, unlimited watchlists with alerts and the trade journal.

Start free See the Sunday Scan

Questions about NHS

Is NHS undervalued right now?

By the GLS models, yes: at 5.35 the stock is 44% below the average fair value of 9.62 (data as of 16 Oct 2026). Whether the discount is deserved is the question to research next.

What is the Wheel Score of NHS and what does it mean?

NHS has no listed options in our nightly snapshot, so it cannot be wheeled; its Wheel Score is capped at 39 and shown as "No options".

What is the GLS fair value for NHS?

9.62 per share as of 16 Oct 2026 - the simple average of the 9 valuation models (out of nine: DCF, Graham Number, Graham Growth, Lynch, GLS Growth, 10 Cap, Payback Time, DDM and EPV) that produced a positive value. The models run every night on the latest filings; the Quote page lets you switch any of them off and add a margin of safety of your own.

When does Neuberger High Yield Strategies Fund Inc. report earnings next?

No upcoming earnings date is recorded for NHS in our calendar as of 16 Oct 2026; the Calendars page is refreshed every morning.

Does NHS have listed options, and how liquid are they?

No. The nightly options snapshot found no listed contracts on NHS, so the wheel strategy cannot be run on it and the Wheel Score is capped at 39.

Data as of 16 Oct 2026: prices and fundamentals from Financial Modeling Prep, option data from Polygon; valuations, scores and the Wheel Score by GLS Equity's models, run nightly. Prices in USD; the close shown is the previous session's. Everything on this page is general information produced by automated models from third-party data - not a recommendation to buy, sell or trade any security or option, and not financial advice. Past performance is not indicative of future results. GLS Equity provides data and tools, not financial advice.